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Abstracts / Urological Science 26 (2015) S36eS49S4625mg/m2, IV, every three to four weeks. Thirty patients ever received prior
docetaxel treatments. The PSA response, pain response, time to progres-
sion duration and adverse events were recorded.
Results: The median age of the thirty-two patients was 65.7 years (range
45e84) and the median PSA when started Cabazitaxel was 65.5 ng/ml
(range 3.82e5239). The mean treatment courses of the patient were 5.9
(range 3e17). PSA declined in twenty-two patients (69%, 22/32) and
eighteen of them (56%, 18/32) got more than 50% declination (PSA
response). The median progression free survival was 6 months. The most
common subjective adverse effects were leukopenia (84%). Ten (31%) pa-
tients had grade 3-4 neutropenia and 4 (12.5%) patients had more than
grade 2 anemia. Liver function impairment was also found in three (9%)
patients.
Conclusions: Cabazitaxel 20-25mg/m2, IV, every three to four weeks were
tolerated and revealed good PSA response in castration resistant prostate
cancer patients. However, high risk of neutropenia should be kept in mind.
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Shyr 1. 1 Sex Hormone Research Center, Departments of Urology/Surgery
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Purpose: Androgen receptor (AR) plays a role in the development and
progression of upper urinary tract urothelial cell carcinoma (UUTUC). Here
we investigated whether AR stimulates UUTUC development and pro-
gression, possibly by expanding the population of cancer stem cells (CSCs),
which are a particular population of cells within cancer cells responsible
for tumor initiation, drug resistance and metastasis.
Materials and methods: We compared BFTC 909 cells with or without the
addition of AR on their CSC population with ﬂow cytometry, colony for-
mation and sphere formation assay to determine the effects of AR on CSC
activity. To observe the effects of AR on BFTC 909 cells, quantitative real-
time PCR was used to detect the expression stemness genes and miRNAs
and western blotting was also performed to examine EMT (epithelial-
mesenchymal transition) related proteins. In vivo tumor formation was
also evaluated with the implantation of cancer cells in nude mice and IHC
was used to detect OCT4 and MMP9 expression on the tumor samples.
Results: We found that the addition of AR in UUTUC cells, (BFTC 909 cell
line) signiﬁcantly increased the population of CSC, clonogenicity, sphere
formation and the expression of stemness genes (Oct4, Bmi1 and Nanog)
and CSC-related miRNA proﬁle as well as EMT related proteins. Further-
more, in an immune-deﬁcient mouse model, the addition of AR in UUTUC
cells also increased the tumor formation.
Conclusions: This study will help us better understand the extent to
which AR contributes to UUTUC by expanding their CSC population and
capacity and could explain high incidence of UUTUC observed in males.
These ﬁndings may lead AR to serve as a potential therapeutic target for
urothelial carcinomas in the future.
MP4-9.
RENAL CLASSIC AND EPITHELIOID ANGIOMYOLIPOMA e EXPERIENCE
OF CHI MEI HOSPITAL AND LITERATURES REVIEW
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of Surgery, Division of Uro-Oncology, Chi-Mei Medical Center, Tainan, Taiwan
Introduction: Renal angiomyolipoma (AML) is a benign neoplasm. There
are two major histologic types of AMLs: classic and epithelioid. Recently
malignant epithelioid variant of angiomyolipoma has been further
described. We would like to compare these two histologic types receiving
surgical treatment of our own experience
Material: We collected 53 cases of renal angiomyolipoma from our hos-
pital receiving surgical intervention from September 2010 to August 2014.
Results: Among these cases, 38 (71.7%) was female with medium age 56.9
year-old. 15 male (28.3%) with medium age 58.7 year-old. 21 of 53 (39.6%)had right side AML with left 30 of 53 (56.6%) and bilateral 1 of 53 (1.9%). 3
of 53 (5.7%) received nephrectomy and 50/53 (94.3%) received partial
nephrectomy. Classic angiomyolipoma accouted for 92.5% (49/53) of all
cases with epithelioid variant 7.5% (4/53). No recurrence was noticed
among classic type with average follow-up length 32.6 months. Recur-
rence was noted in one of epithelioid variant in 31 months follow-up.
Conclusion: Renal angiomyolipoma is a benign neoplasm consisting of
thick-walled aneurysmal vessels, smooth muscle, and varying levels of
mature adipose tissue. Recently malignant epithelioid variant of angio-
myolipoma has been further described since it was presented on 1997 by
Eble and colleagues. Here, We compared these two histologic types
receiving surgical treatment of our own experience and we would like to
compared it with data of other institute to see of there’s any differences
and the cause leading to it.
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Purpose: Retroperitoneal liposarcomas are rare malignant tumor with an
aggressive disease course and high recurrent rate. In this article, we will
share our experience in treating retroperitoneal liposarcoma and describe
the tumor behavior we observed.
Materials and methods: During January 2010 to December 2014, 11 pa-
tient are treated in our hospital for retroperitoneal liposarcomas. We re-
view the treatments (surgical or non-surgical), clinical presentation, tumor
behavior, pathological subtype, and the characteristics of recurrent tumor.
Results: There are 11 patients of retroperitoneal liposarcoma enrolled in
this analysis. 9 patients are female, and 2 are male. 7 patients are well-
differentiated liposarcoma, and 4 are de-differentiated liposarcoma. One
patient died one month after surgical excision of tumor because of
pneumonia. One patient has no recurrence in 3 years of follow-up. One has
bone metastasis at the time of diagnosis. 8 patients are found recurrent
and receive repeated surgical excision of tumor, and 3 of them experience
second recurrence. One patient experience third recurrence, and one has
forth recurrence. The mean time to recurrence is 40 months. 4 patients
have surgical margin involved with tumor, and the mean recurrence time
in this subgroup is 5 months.
Conclusions: During the past 4 years, 11 patients with retroperitoneal
liposarcoma receiving surgical excision of tumor have been followed at our
hospital. There is no obvious difference in tumor recurrence between pa-
thology subtypes. Patients with positive surgical margin experience
shorter time to recurrence.Moderated Poster-5Oncology
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THE INFLUENCE OF INTRAVESICAL PROSTATIC PROTRUSION AND POST
OPERATIVE CONTINENCE AFTER PATIENTS RECEIVED ROBOTIC
ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY
Sheng-Chun Hung, Yen-Chuan Ou PhD, Cheng-Kuang Yang. Divisions of
Urology, Department of Surgery, Taichung Veterans General Hospital, Taiwan
Purpose: We try to evaluate the inﬂuence of intravesical prostatic pro-
trusion (IPP) in the postoperative continence of patient who received ro-
botic assisted laparoscopic radical prostatectomy.
Materials and methods: A total 600 patients who underwent robotic
assisted laparoscopic radical prostatectomy were included in the study.
Preoperative MRI was performed in all patients and the vertical distance
from the tip of the protruding prostate to the base of the urinary bladder
was measured in all sagittal plane. The degree of intravesical prostatic
protrusion were divided into three groups ( IPP<5mm, 5mm<IPP<10mm,
